Chrome Extension
WeChat Mini Program
Use on ChatGLM

Bimekizumab efficacy and safety through three years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE randomized controlled trial and the BE BRIGHT open-label extension

SKIN The Journal of Cutaneous Medicine(2022)

Cited 1|Views6
No score
Abstract
N/A
More
Translated text
Key words
severe plaque psoriasis,long-term,open-label
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined